CAS: 943609-66-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | Vedolizumab REF: TM-T9914CAS: 943609-66-3 | SDS-PAGE:98.4%;SEC-HPLC:99.1% | 188,00 €~2.072,00 € | Vie 28 Mar 25 |
 | Vedolizumab REF: 3D-BV165597CAS: 943609-66-3 | Min. 95% | 558,00 €~1.714,00 € | Jue 08 May 25 |
Vedolizumab
CAS:943609-66-3
Vedolizumab is a humanized monoclonal antibody that targets the α4β7 integrin for the treatment of …
Pureza:
SDS-PAGE:98.4%;SEC-HPLC:99.1%
Forma y color:
Liquid
Peso molecular:
146.80 kDa
Ref: TM-T9914
| 1mg | 188,00 € | ||
| 5mg | 512,00 € | ||
| 10mg | 740,00 € | ||
| 25mg | 1.121,00 € | ||
| 50mg | 1.510,00 € | ||
| 100mg | 2.072,00 € |
Entrega estimada en Estados Unidos, el Viernes 28 de Marzo de 2025
Vedolizumab
CAS:943609-66-3
Inhibits lymphocyte adhesion to mucosal endothelium; Crohn's disease therapy
Pureza:
Min. 95%
Ref: 3D-BV165597
| 1mg | 1.071,00 € | ||
| 2mg | 1.357,00 € | ||
| 5mg | 1.714,00 € | ||
| 250µg | 558,00 € | ||
| 500µg | 759,00 € |
Entrega estimada en Estados Unidos, el Jueves 8 de Mayo de 2025
